Gongwei Han

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer

Quan Xia, Ziwei Cheng, Jiemei Jiang, 2022, Frontiers in Pharmacology.